Genespire
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.
Genespire has raised €16M across 1 funding round from 1 investor, most recently a Series A round in Apr 2020. Based in Milan, Italy; founded 2020; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€16M
€16,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2020-04
latest 2020-04
Funding by year
EUR raised per yearGenespire — funding by year — interactive chart.
Data table
| Genespire — funding by year | |
|---|---|
| 2020 | €16M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-04-29 | Series A | €16M | Sofinnova Partners | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bending Spoons€1.7BItaly · Software
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData